Hemophilia Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 19
SKU : PH2672
excelpdfpowerpoint
180 pages
Report Summary
Table of Content
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Hemophilia Market ?
Global Hemophilia Market reached USD 11.7 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 18 billion by 2031.
Who are the Key Players of Hemophilia Market ?
Major players Bayer AG, BioMarin Pharmaceutical, Inc., CSL Behring, Kedrion S.p.A, Novo Nordisk, Pfizer, Inc., Roche (Chugai Pharmaceutical Co.), Sanofi (Genzyme Corporation), and Takeda Pharmaceutical (Shire Plc.) and Grifols.
Related Reports
clinical-diagnostics

Lyme Disease Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 December 29
Starting from

$4350

clinical-diagnostics

Predictive Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 February 03
Starting from

$4350

medical-devices

Rapid Medical Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 04
Starting from

$4350

medical-devices

Tissue Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 April 12
Starting from

$4350

veterinary-health

Veterinary Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 09
Starting from

$4350

clinical-diagnostics

Malaria Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 February 03
Starting from

$4350